213598-15-3

Basic information

• Product Name: 3-CHLORO-4-ETHOXYBENZOIC ACID 97
• Synonyms: 3-CHLORO-4-ETHOXYBENZOIC ACID 97;3-Chloro-4-ethoxybenzoic acid;3-chloro-4-ethoxybenzoic acid(SALTDATA: FREE)
• CAS NO: 213598-15-3
• Molecular Formula: C₉H₉ClO₃
• Molecular Weight: 200.62
• Product Categories: C9;Carbonyl Compounds;Carboxylic Acids
• Mol File: 213598-15-3.mol
• Article Data: 4

Chemical Properties

• Melting Point: 211-215 °C(lit.)
• Boiling Point: 317.1 °C at 760 mmHg
• Flash Point: 145.6 °C
• Appearance: solid
• Density: 1.299 g/cm³
• Vapor Pressure: 0.000165mmHg at 25°C
• Refractive Index: 1.552
• PKA: 4.12±0.10(Predicted)
• CAS DataBase Reference: 3-CHLORO-4-ETHOXYBENZOIC ACID 97(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-4-ETHOXYBENZOIC ACID 97(213598-15-3)
• EPA Substance Registry System: 3-CHLORO-4-ETHOXYBENZOIC ACID 97(213598-15-3)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 213598-15-3(Hazardous Substances Data)

Usage

General Description

3-Chloro-4-ethoxybenzoic acid 97 is a chemical compound with the molecular formula C9H9ClO3. It is a white to off-white crystalline solid that is soluble in organic solvents. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also used in the manufacturing of dyes, pigments, and other specialty chemicals. 3-Chloro-4-ethoxybenzoic acid 97 is known for its high purity, making it suitable for various industrial and research applications.

InChI:InChI=1/C9H9ClO3/c1-2-13-8-4-3-6(9(11)12)5-7(8)10/h3-5H,2H2,1H3,(H,11,12)

Upstream product

• 99585-10-1 4-ethoxy-3-chloro-benzaldehyde 
• 473-34-7 N,N-dichloro-p-toluenesulfonamide 
• 619-86-3 4-(ethoxy)benzoic acid 
• 192512-43-9 4-ethoxy-3-chloro-benzoic acid methyl ester 

Downstream Products

• 1072947-86-4 ethyl 3-(5-{5-[3-chloro-4-(ethyloxy)phenyl]-1,2,4-oxadiazol-3-yl}-1H-indazol-1-yl)propanoate 
• 1417560-71-4 C₂₁H₁₆ClNO₂S 

Relevant articles and documents

S1P RECEPTORS MODULATORS

The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.

Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity

Compounds of formula (I) and pharmaceutically acceptable salts and solvates: where R1is hydrogen, C1-6alkyl (optionally substituted by hydroxy or C1-4alkoxy), phenyl-C1-4alkyl-, C1-6alkenyl, C1-6